GG 1978 Sicaf Sif S.A. - GG Strategic's Form 4 filing
Royalty Pharma plc (RPRX) · filed Aug 29, 2022
- Accession no.
- 0001140361-22-031350
- Filed
- Aug 29, 2022, 5:41 PM ET
- Trade date
- Aug 25, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $87.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| GG 1978 Sicaf Sif S.A. - GG StrategicCIK 0001814890 | 10% Owner |
| GG 1978 Sicaf Sif S.A.CIK 0001814891 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | Class A Ordinary Shares | SSaleDisposed | −1,994 | $44.00 | −$87,736 | 22,924,176 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.